Results 251 to 260 of about 209,786 (306)

Heart Rate Metrics as Potential Biomarkers for Predicting Transcranial Magnetic Stimulation Treatment Response in Treatment-Resistant Depression

Chang H, Chang C, Lai T, Chang H, Liu Y, Sack A.   +5 more
europepmc   +1 more source

Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response. [PDF]

BMC Psychiatry
Baune BT, Rosemann K, Hefter D, Tonkul M, Kavakbasi E.   +4 more
europepmc   +1 more source

Arthroscopic Treatment of Schatzker Type III Tibial Plateau Fractures Using a Combination of Bioabsorbable Interference Screws and Cannulated Screws

Arthroscopy Techniques, EarlyView.
Abstract Schatzker type III tibial plateau fractures, characterized by a pure depression of the lateral articular surface, predominantly affect osteoporotic, middle‐aged, and elderly patients. Successful management requires anatomical reduction and stable fixation to minimize complications like post‐traumatic arthritis.
Renbang Huang, Zeming Li, Xifan Zheng, Jun Yao   +3 more
wiley   +1 more source

Role of Genetic and Epigenetic Biomarkers in Treatment-Resistant Depression: A Literature Review. [PDF]

Genes (Basel)
Sulić P, Ražić Pavičić A, Đapić Ivančić B, Božina T, Božina N, Živković M.   +5 more
europepmc   +1 more source

Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression. [PDF]

Ther Adv Psychopharmacol
Patarroyo-Rodriguez L, Pazdernik VK, Vande Voort JL, Kung S, Singh B.   +4 more
europepmc   +1 more source

Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study. [PDF]

Ther Adv Psychopharmacol
Cuomo A, McIntyre R, Koukouna D, Pinzi M, Pardossi S, Firenzuoli B, Barillà G, Carmellini P, Alamia A, Fagiolini A.   +9 more
europepmc   +1 more source

Toward Integrating Intranasal Esketamine with Traumatic-Memory Psychotherapy in Treatment-Resistant Depression: A Narrative Review and Feasibility-Oriented Protocol Proposal. [PDF]

Behav Sci (Basel)
Raffone F, Cattaneo CI, Pessina E, Martini A, Martiadis V.   +4 more
europepmc   +1 more source

Association Between Plasma SITH-1 Antibody Titers and Treatment Trajectory of Treatment-Resistant Depression. [PDF]

Neuropsychopharmacol Rep
Mori K, Kodaka F, Ishii J, Oka N, Kondo K, Kito S.   +5 more
europepmc   +1 more source